These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19107443)

  • 1. Aberrant crypt foci in colon cancer epidemiology.
    Khare S; Chaudhary K; Bissonnette M; Carroll R
    Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
    Ziliotto L; Barbisan LF; Rodrigues MA
    Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa.
    Vaccina F; Scorcioni F; Pedroni M; Tamassia MG; De Leon MP; De Pol A; Marzona L; Roncucci L
    Anticancer Res; 1998; 18(5A):3451-6. PubMed ID: 9858923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
    Furihata T; Kawamata H; Kubota K; Fujimori T
    Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
    Mori H; Yamada Y; Kuno T; Hirose Y
    Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous development of aberrant crypt foci in F344 rats.
    Furukawa F; Nishikawa A; Kitahori Y; Tanakamaru Z; Hirose M
    J Exp Clin Cancer Res; 2002 Jun; 21(2):197-201. PubMed ID: 12148578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant crypt foci in human colon carcinogenesis.
    Dolara P; Caderni G; Lancioni L; Giannini A; Anastasi A; Fazi M; Castiglione G
    Cancer Detect Prev; 1997; 21(2):135-40. PubMed ID: 9101074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant crypts: putative preneoplastic foci in human colonic mucosa.
    Pretlow TP; Barrow BJ; Ashton WS; O'Riordan MA; Pretlow TG; Jurcisek JA; Stellato TA
    Cancer Res; 1991 Mar; 51(5):1564-7. PubMed ID: 1997197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetic evaluation of human colonic aberrant crypts. (Colorectal Cancer Study Group of the University of Modena and the Health Care District 16, Modena, Italy).
    Roncucci L; Pedroni M; Fante R; Di Gregorio C; Ponz de Leon M
    Cancer Res; 1993 Aug; 53(16):3726-9. PubMed ID: 8339283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability in aberrant crypt foci from human colons.
    Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
    Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased frequency of serrated aberrant crypt foci among smokers.
    Anderson JC; Pleau DC; Rajan TV; Protiva P; Swede H; Brenner B; Heinen CD; Lambrecht RW; Rosenberg DW
    Am J Gastroenterol; 2010 Jul; 105(7):1648-54. PubMed ID: 20234347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
    Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer.
    Karthik Kumar V; Vennila S; Nalini N
    Food Chem Toxicol; 2009 Feb; 47(2):309-15. PubMed ID: 19056454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.